Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer. [electronic resource]
Producer: 20110509Description: 1075-82 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor -- blood
- Carcinoma, Non-Small-Cell Lung -- blood
- Czech Republic
- Disease-Free Survival
- Double-Blind Method
- Female
- Glutamates -- administration & dosage
- Guanine -- administration & dosage
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- blood
- Male
- Middle Aged
- Pemetrexed
- Proportional Hazards Models
- Risk Assessment
- Risk Factors
- Sulfonamides -- administration & dosage
- Time Factors
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.